Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

THC Kiss and Pure Cannabis Sticks in Production

C.THC

THC.CSE
THCBF
- OTC
TFHC.F

VANCOUVER, March 10, 2020 /CNW/ - THC BioMed Intl Ltd. ("THC" or the "Company") is pleased to report that our Pure Cannabis Sticks and THC Kiss are now in production at our flagship Acland Road location.

THC BioMed (CNW Group/THC BioMed)

THC is pleased to report that it has acquired all regulatory permissions to begin the production of its Pure Cannabis Sticks and THC Kiss.

THC's consulting engineers and Quality Assurance team are currently monitoring initial production of the Pure Cannabis Sticks and fine tuning the automated production machine for product quality. Images of our end product will be posted on the Company's website.
Pure Cannabis Sticks have biodegradable filters and are expected to be sold in packs of 1, 4, and 25.

THC Kiss, THC's cannabis beverage, also has gone into production and will be distributed to medical patients first with the roll out extending to the provinces shortly thereafter.

THC expects to release THC Kiss for sale to medical patients within the next 30 days.

AboutTHC

THC is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. THC is Canada's largest supplier of legal cannabis genetics. The Company is on the leading edge of scientific research and the development of products and services related in the medical cannabis industry. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.

Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC. Forward-looking information is based on certain key expectations and assumptions made by the management of THC. In some cases, you can identify forward-looking statements by the use of words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this release are made as of the date of this press release and include that (a) Pure Cannabis Sticks will be sold in packs of 1, 4, and 25, (b) THC Kiss will be released to medical patients in the next 30 days, with the roll out extending to the provinces shortly thereafter, and (c) THC will be on the forefront of this rapidly growing industry. Although THC believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC can give no assurance that they will prove to be correct. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thc-kiss-and-pure-cannabis-sticks-in-production-301020204.html

SOURCE THC BioMed

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2020/10/c6455.html

President and CEO: John Miller, THC Biomed Intl Ltd., T: 1-844-THCMEDS, E: info@thcbiomed.comCopyright CNW Group 2020